Assessment of remote digital auscultation for identifying significant aortic stenosis: A pilot study.

Arch Cardiovasc Dis

Department of Cardiology, Lady Davis Carmel Medical Center, 7 Michal St., Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Aortic stenosis (AS) is the most common valvular disease in the Western world. Technological advances, such as the TytoCare™ device, have introduced remote telemedicine-based cardiac auscultation. Its utility in diagnosing and grading AS remains unexplored. This study aims to evaluate the reliability of the TytoCare™ for assessing AS.

Methods: Sixty patients were classified by standard echocardiogram into three groups: significant AS (at least moderate AS; n=20), non-significant AS (aortic sclerosis or mild AS; n=20) and controls (n=20). Heart sounds were self-recorded using the TytoCare™ stethoscope. Fifteen blinded physicians - five each from primary care, internal medicine and cardiology - reviewed the recordings using standardized equipment and assigned diagnoses based on a categorical scale: 0=insufficient data, 1=normal, 2=mild AS and 3=at least moderate AS.

Results: The study groups had comparable baseline characteristics, with a mean±standard deviation age of 72.6±9.1years. The correct response rate for significant AS was 85% (95% confidence interval [95% CI]: 80-88%), with both cardiologists and non-cardiologists achieving≥80%. In contrast, performance declined in non-significant AS (57%, 95% CI: 51-62%), but remained high in the control group (87%, 95% CI: 82-90%). Cardiologists outperformed other physicians, overall (P=0.029) and in significant AS cases (P=0.022), while no significant differences were found among non-cardiologists.

Conclusions: TytoCare™ demonstrated high reliability in the remote assessment of significant AS by both cardiologists and non-cardiologists. Its intuitive and user-friendly design enables self-application, even among older populations, emphasizing its potential as an effective screening tool for AS across diverse healthcare settings.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acvd.2025.06.072DOI Listing

Publication Analysis

Top Keywords

aortic stenosis
8
cardiologists non-cardiologists
8
assessment remote
4
remote digital
4
digital auscultation
4
auscultation identifying
4
identifying aortic
4
stenosis pilot
4
pilot study
4
study background
4

Similar Publications

[The TAVI heart team].

Herz

September 2025

Department of Cardiology, Heart Center Leipzig, University of Leipzig, Strümpellstraße 39, 04289, Leipzig, Deutschland.

Since the earliest studies on transcatheter aortic valve implantation (TAVI), the heart team concept has been an integral component of treatment planning for patients with aortic valve stenosis (AS). The primary objective is to ensure patient-specific, guideline-based treatment through the structured involvement of all relevant medical disciplines. The TAVI heart team is strongly recommended with a class I indication in both European and US clinical guidelines.

View Article and Find Full Text PDF

Introduction: Whilst aortic stenosis remains the most prevalent valvular abnormality, the management of asymptomatic severe aortic stenosis remains a clinical challenge. Recently, two randomised-controlled trials (RCTs) - EVOLVED (Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis) and Early TAVR (Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis) - have been published, alongside an extended follow-up from the AVATAR (Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis) study.

Evidence Acquisition: In response, we conducted a systematic review of PubMed, Ovid, and Cochrane databases, identifying RCTs up to October 29, 2024, that compared early intervention with conventional management.

View Article and Find Full Text PDF

Aortic valve stenosis is a progressive and increasingly prevalent disease in older adults, with no approved pharmacologic therapies to prevent or slow its progression. Although genetic risk factors have been identified, the contribution of epigenetic regulation remains poorly understood. Here, we demonstrated that histone deacetylase 3 (HDAC3) maintains aortic valve structure by suppressing mitochondrial biogenesis and preserving extracellular matrix integrity in valvular interstitial fibroblasts.

View Article and Find Full Text PDF

Subaortic membrane (SAM) is a subtype of left ventricular outflow obstruction, rarely seen in adults. In some cases, SAM may be associated with other congenital defects. The association of patent ductus arteriosus (PDA) and SAM is the rarest, especially in adult patients.

View Article and Find Full Text PDF

Background: Mitral valve surgery is a widely performed intervention for the treatment of various mitral valve pathologies. Postoperative conduction disturbances may necessitate permanent pacemaker (PPM) implantation. This study aims to identify and quantify patient-related, cardiovascular, procedural risk factors, and risk score-based predictors of PPM implantation following mitral valve surgery.

View Article and Find Full Text PDF